These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38505035)

  • 1. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
    J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
    Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
    Jiang L; Liang W; Shen J; Chen X; Shi X; He J; Yang C; He J
    Chest; 2015 Oct; 148(4):903-911. PubMed ID: 25675151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study.
    Park HJ; Park HS; Cha YJ; Lee S; Jeung HC; Cho JY; Kim HJ; Byun MK
    J Thorac Dis; 2018 Apr; 10(4):2279-2287. PubMed ID: 29850132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
    Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
    Front Oncol; 2022; 12():830470. PubMed ID: 35280762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of visceral pleural invasion in the stage pT
    Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
    Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors.
    Choi J; Oh JY; Lee YS; Min KH; Shim JJ; Choi SI; Park DW; Park CK; Kang EJ; Yong HS; Shin BK; Kim HK; Lee SY
    Korean J Intern Med; 2022 Jan; 37(1):127-136. PubMed ID: 32872735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors for Survival of Stage IB Non-small Cell Lung Cancer Patients: A 10-Year Follow-Up Retrospective Study.
    Yang Z; Li X; Bai J; Li D; Ma Z; Deng C; Fu F; Zhang Y
    Ann Surg Oncol; 2023 Nov; 30(12):7481-7491. PubMed ID: 37535274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.
    Lee PH; Chiang CJ; Tseng JS; Zheng ZR; Chen KC; Chu CH; Huang YH; Hsu KH; Lee WC; Yang TY; Liu TW; Hsia JY; Chang GC
    Front Oncol; 2023; 13():1096683. PubMed ID: 36925928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in stage IB non-small cell lung cancer according to the 8
    Moon Y; Choi SY; Park JK; Lee KY
    J Thorac Dis; 2019 Dec; 11(12):5352-5361. PubMed ID: 32030253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.
    Fibla JJ; Cassivi SD; Brunelli A; Decker PA; Allen MS; Darling GE; Landreneau RJ; Putnam JB
    Lung Cancer; 2012 Dec; 78(3):259-62. PubMed ID: 23040416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
    Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
    Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.